November 14-15, 2022 | Washington, DC 


Learn about the latest technologies, partnerships and advances propelling the field of repurposing and re-shaping drug discovery and development


The next Drug Repositioning & Repurposing Conference will be taking place in Spring/Summer 2024. Please check back in the coming weeks and months for updates.

2015 Speakers

Roy Anderson, Group VP of Marketing Strategy and Commercial Development, Horizon Pharma plc
Bruce Bloom, DDS, JD, President and Chief Science Officer, Cures Within Reach
Gauthier Bouche, MD, Medical Director, Anticancer Fund
Christine Colvis, Ph.D., Director, Drug Development Partnership Programs, National Center for Advancing Translational Sciences (NCATS), NIH
Daniel M. Czyz, Ph.D., Postdoctoral Scholar/Crosson Lab, Department of Biochemistry & Molecular Biology, University of Chicago
Sivanesan Dakshanamurthy, Ph.D., Associate Professor of Oncology, Clinical & Experimental Therapeutics Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center 
Chris Gibson, Ph.D, MD, Chief Executive Officer, Recursion Pharmaceuticals
Tim Guilliams, Ph.D., Chief Executive, Healx
Raul Insa, MD, Ph.D., MBA, Founder and CEO, SOM Biotech
Alexander Ivliev, Ph.D., Senior Scientist, Thomson Reuters Life Sciences
Hermann Mucke, Ph.D., Chief Executive, H.M. Pharma Consultancy
Stephen Naylor, Ph.D., Chairman & CEO, MaiHealth Inc.
Aris Persidis, Ph.D., President, Biovista
James Pickett, Ph.D., Head of Research, Alzheimer's Society
Tomasz Sablinski, MD, Ph.D., Chief Executive Officer, Transparency Life Sciences
Mohamed Seleem, Ph.D., Assistant Professor of Microbiology, Department of Comparative Pathobiology, Purdue University School of Veterinary Medicine
E. Mitchell Seymour, Ph.D., RAC., Director, Founder, R&D Advisors LLC, Faculty, University of Michigan Institute for Clinical and Health Research
Craig Webb, Ph.D., Chief Scientific Officer, NuMedii
Scott Weir, PharmD, Ph.D., Director, Institute for Advancing Medical Innovation, Associate Director, Translational Research, University of Kansas Cancer Center, Professor, Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center
Dr. Richard Wyse, Director of Research and Development, The Cure Parkinson's Trust

Contact Us

Arrowhead Publishers
PO Box 96
Chanhassen, MN 55317


About Us

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward.